Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Website: bauschhealth.com


  • Good financial results growth rate 16.7% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (27.6%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 12.6% (LTM)
  • Share price is 66.9% higher than minimum and 32.0% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (11.5x vs 11.5x)
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders bought company shares on $15.6 mln (0.690% of cap.)

Key Financials (Download financials)

Ticker: BHC
Share price, USD:  (0.0%)7.21
year average price 6.42  


year start price 7.88 2025-01-11

min close price 4.32 2025-04-11

max close price 8.34 2025-08-15

current price 7.21 2026-01-10
Common stocks: 362 239 735

Dividend Yield:  0.0%
FCF Yield LTM: 12.6%
EV / LTM EBITDA: 11.5x
EV / EBITDA annualized: 6.6x
Last revenue growth (y/y):  +6.1%
Last growth of EBITDA (y/y):  +27.3%
Historical revenue growth:  +21.3%
Historical growth of EBITDA:  +33.9%
EV / Sales: 2.5x
Margin (EBITDA LTM / Revenue): 21.9%

Target EV / EBITDA (hist percentile): 11.5x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 2 612
Net Debt ($m): 21 392
EV (Enterprise Value): 24 004
EBITDA LTM (млн $): 2 083
EV / LTM EBITDA: 11.5x
Price to Book: -4.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-12-29247wallst.com

2 Strong Mid-Cap Growth Stocks Dan Loeb Bought in Q3

2025-12-23accessnewswire.com

Bausch Health Announces Final Results and Expiration of Exchange Offers

2025-12-10fool.com

Bausch Health's Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake

2025-12-08accessnewswire.com

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

2025-12-02seekingalpha.com

Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript

2025-12-01fool.com

Why Bausch Health Companies Stock Rocketed 11% Higher Today

2025-11-24accessnewswire.com

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

2025-11-11seekingalpha.com

Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path

2025-10-31seekingalpha.com

Why Bausch Health Is A Buy After Rising 10% On Third-Quarter Results

2025-09-11seekingalpha.com

Bausch Health: Repricing Continues As Deleveraging Gains Traction
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol BHC BHC BHC BHC BHC BHC BHC BHC BHC BHC BHC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590
fillingDate 2025-10-30 2025-07-31 2024-10-31 2024-08-01 2024-05-02 2024-02-22 2023-11-02 2023-08-03 2023-05-04 2023-02-23 2022-11-03
acceptedDate 2025-10-29 18:09:46 2025-07-30 18:36:32 2024-10-30 19:13:33 2024-08-01 16:45:52 2024-05-02 16:57:48 2024-02-22 17:04:26 2023-11-02 16:58:48 2023-08-03 16:46:59 2023-05-04 16:41:21 2023-02-23 16:37:29 2022-11-03 16:50:45
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 912M 2 530M 2 510M 2 403M 2 143M 2 408M 2 238M 2 167M 1 944M 2 193M 2 046M
costOfRevenue -668M 764M 978M 989M 910M -1 814M 623M 649M 582M 652M 584M
grossProfit 1 580M 1 766M 1 532M 1 414M 1 233M 4 222M 1 615M 1 518M 1 362M 1 541M 1 462M
grossProfitRatio 1.732 0.698 0.61 0.588 0.575 1.753 0.722 0.701 0.701 0.703 0.715
researchAndDevelopmentExpenses 166M 160M 161M 156M 150M 152M 153M 156M 143M 142M 133M
generalAndAdministrativeExpenses 0 0 0 0 0 141M 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 625M 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 795M 894M 850M 832M 790M 766M 715M 711M 725M 666M 661M
otherExpenses 0 268M 0 -3M 0 -235M -60M -1M 296M 342M 290M
operatingExpenses 961M 1 322M 996M 988M 941M 918M 1 121M 1 053M 1 164M 1 150M 1 084M
costAndExpenses 293M 2 086M 1 982M 1 977M 1 851M -896M 1 744M 1 702M 1 746M 1 802M 1 668M
interestIncome 15M 13M 7M 8M 9M 7M 6M 7M 6M 6M 3M
interestExpense 2 002M 465M 346M 350M 355M -2 293M 339M 319M 307M 307M 385M
depreciationAndAmortization 300M 307M 325M 318M 319M 43 812 253M 269M 302M 313M 335M
ebitda 2 520M 764M 647M 719M 611M -3 124M 693M 741M 477M 710M 716M
ebitdaratio 2.763 0.302 0.258 0.31 0.285 -1.297 0.31 0.342 0.245 0.324 0.35
operatingIncome 619M 444M 318M 426M 293M 362M 14M 412M 175M 397M 381M
operatingIncomeRatio 0.679 0.175 0.127 0.177 0.137 0.15 0.006 0.19 0.09 0.181 0.186
totalOtherIncomeExpensesNet -401M -304M -339M -341M -361M -369M -487M -74M -311M -754M 58M
incomeBeforeTax 218M 140M -21M 48M -69M -7M -326M 79M -136M -357M 439M
incomeBeforeTaxRatio 0.239 0.055 -0.008 0.02 -0.032 -0.003 -0.146 0.036 -0.07 -0.163 0.215
incomeTaxExpense 39M 12M 72M 49M 8M -402M 56M 52M 73M 53M 36M
netIncome 179M 148M -85M 10M -64M 395M -378M 26M -209M -410M 399M
netIncomeRatio 0.196 0.058 -0.034 0.004 -0.03 0.164 -0.169 0.012 -0.108 -0.187 0.195
eps -0.24 0.4 -0.23 0.027 -0.17 1.08 -1.03 0.07 -0.58 -1.13 1.1
epsdiluted -0.24 0.4 -0.23 0.027 -0.17 1.08 -1.03 0.07 -0.58 -1.13 1.1
weightedAverageShsOut 371M 371M 368M 368M 367M 365M 365M 371M 363M 363M 363M
weightedAverageShsOutDil 373M 373M 368M 370M 367M 365M 365M 371M 363M 363M 363M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol BHC BHC BHC BHC BHC BHC BHC BHC BHC BHC BHC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590
fillingDate 2025-10-30 2025-07-31 2024-10-31 2024-08-01 2024-05-02 2024-02-22 2023-11-02 2023-08-03 2023-05-04 2023-02-23 2022-11-03
acceptedDate 2025-10-29 18:09:46 2025-07-30 18:36:32 2024-10-30 19:13:33 2024-08-01 16:45:52 2024-05-02 16:57:48 2024-02-22 17:04:26 2023-11-02 16:58:48 2023-08-03 16:46:59 2023-05-04 16:41:21 2023-02-23 16:37:29 2022-11-03 16:50:45
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 1 339M 1 727M 719M 623M 754M 947M 760M 767M 518M 564M 486M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 1 339M 1 727M 719M 623M 754M 947M 760M 767M 518M 564M 486M
netReceivables 2 415M 2 210M 2 094M 2 102M 2 046M 1 998M 1 948M 2 310M 1 688M 1 790M 1 739M
inventory 1 596M 1 655M 1 655M 1 612M 1 634M 1 544M 1 272M 1 643M 1 222M 1 090M 1 056M
otherCurrentAssets 893M 922M 883M 902M 956M 1 092M 1 048M 1 179M 796M 776M 718M
totalCurrentAssets 6 243M 6 514M 5 351M 5 210M 5 390M 5 596M 5 048M 5 912M 4 237M 4 247M 4 010M
propertyPlantEquipmentNet 2 024M 1 994M 1 789M 1 738M 1 711M 1 707M 1 584M 2 119M 1 596M 1 600M 1 507M
goodwill 11 276M 11 298M 11 171M 11 125M 11 148M 11 183M 11 187M 15 410M 11 579M 11 547M 12 044M
intangibleAssets 4 825M 5 047M 5 652M 5 903M 6 183M 6 456M 6 728M 7 022M 5 552M 5 800M 6 024M
goodwillAndIntangibleAssets 16 101M 16 345M 16 823M 17 030M 17 343M 17 639M 17 915M 22 432M 17 131M 17 347M 18 068M
longTermInvestments 0 0 0 -2M -18M 0 0 0 0 0 0
taxAssets 2 048M 2 025M 2 188M 2 187M 2 147M 2 101M 2 189M 2 904M 2 163M 2 166M 2 372M
otherNonCurrentAssets 382M 388M 389M 329M 312M 307M 328M 431M 318M 326M 341M
totalNonCurrentAssets 20 555M 20 752M 21 189M 21 281M 21 495M 21 754M 22 016M 27 885M 21 208M 21 439M 22 288M
otherAssets 0 0 0 1 0 0 0 0 0 0 0
totalAssets 26 798M 27 266M 26 540M 26 491M 26 885M 27 350M 27 064M 33 797M 25 445M 25 686M 26 298M
accountPayables 615M 627M 667M 579M 641M 719M 569M 682M 561M 521M 486M
shortTermDebt 578M 879M 453M 452M 537M 450M 536M 588M 446M 432M 411M
taxPayables 0 0 102M 78M 76M 47M 70M 69M 46M 30M 66M
deferredRevenue 0 0 0 78M 76M 2 092M 2 771M 2 531M 0 0 0
otherCurrentLiabilities 3 594M 3 469M 3 284M 3 260M 3 146M 1 041M 348M 1 455M 2 916M 2 988M 2 934M
totalCurrentLiabilities 4 788M 4 975M 4 506M 4 368M 4 400M 4 302M 4 224M 5 257M 3 923M 3 941M 3 831M
longTermDebt 20 443M 20 859M 21 054M 21 208M 21 514M 21 938M 21 894M 26 647M 20 207M 20 334M 20 804M
deferredRevenueNonCurrent 0 0 0 1 1 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 145M 144M 169M 170M 170M 163M 213M 285M 205M 202M 422M
otherNonCurrentLiabilities 1 066M 1 141M 1 053M 1 145M 975M 1 029M 968M 1 248M 965M 949M 21 137M
totalNonCurrentLiabilities 21 654M 22 144M 22 276M 22 350M 22 659M 23 130M 23 075M 28 181M 21 377M 21 485M 22 034M
otherLiabilities 0 0 0 1 1 0 0 0 0 0 0
capitalLeaseObligations 0 0 0 0 0 147M 0 0 0 0 0
totalLiabilities 26 442M 27 119M 26 782M 26 718M 27 059M 27 432M 27 299M 33 438M 25 300M 25 426M 25 865M
preferredStock 0 0 0 0 0 0 0 61M 0 0 0
commonStock 10 505M 10 510M 10 489M 10 481M 10 469M 10 423M 10 420M 13 798M 10 405M 10 391M 10 387M
retainedEarnings -9 546M -9 734M -9 917M -9 831M -9 832M -9 778M -9 739M -12 405M -9 387M -9 186M -8 776M
accumulatedOtherComprehensiveIncomeLoss -1 798M -1 790M -1 947M -2 007M -1 915M -1 881M -2 051M -2 521M -1 989M -2 056M -2 265M
othertotalStockholdersEquity 275M 250M 201M 181M 164M 214M 190M 188M 171M 159M 129M
totalStockholdersEquity -564M -764M -1 174M -1 175M -1 114M -1 022M -1 180M -879M -800M -692M -525M
totalEquity 356M 147M -242M -227M -174M -82M -235M 359M -800M -692M -525M
totalLiabilitiesAndStockholdersEquity 26 798M 27 266M 26 540M 26 491M 26 885M 27 350M 27 064M 33 797M 25 445M 25 686M 26 298M
minorityInterest 920M 911M 932M 948M 940M 940M 945M 1 238M 945M 952M 0
totalLiabilitiesAndTotalEquity 26 798M 27 266M 26 540M 26 491M 26 885M 27 350M 27 064M 33 797M 25 445M 25 686M 26 298M
totalInvestments 0 0 0 -2M -18M 0 0 0 0 0 0
totalDebt 21 021M 21 738M 21 507M 21 657M 22 051M 22 388M 22 430M 27 236M 20 653M 20 766M 21 215M
netDebt 19 683M 20 011M 20 788M 21 034M 21 297M 21 441M 21 670M 26 468M 20 135M 20 202M 20 729M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol BHC BHC BHC BHC BHC BHC BHC BHC BHC BHC BHC
reportedCurrency USD USD USD USD USD USD USD CAD USD USD USD
cik 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590 885 590
fillingDate 2025-10-30 2025-07-31 2024-10-31 2024-08-01 2024-05-02 2024-02-22 2023-11-02 2023-08-03 2023-05-04 2023-02-23 2022-11-03
acceptedDate 2025-10-29 18:09:46 2025-07-30 18:36:32 2024-10-30 19:13:33 2024-08-01 16:45:52 2024-05-02 16:57:48 2024-02-22 17:04:26 2023-11-02 16:58:48 2023-08-03 16:46:59 2023-05-04 16:41:21 2023-02-23 16:37:29 2022-11-03 16:50:45
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome 181M 128M -92M 10M -64M -47M -382M 42M -209M -410M 403M
depreciationAndAmortization 306M 307M 322M 318M 319M 329M 301M 409M 319M 360M 335M
deferredIncomeTax -24M -42M -3M -44M -57M 84M -3M -40M 0 19M -96M
stockBasedCompensation 43M 46M 38M 36M 33M 29M 29M 43M 41M 35M 33M
changeInWorkingCapital -53M -72M 126M 32M -35M -170M -148M -267M -61M -22M -269M
accountsReceivables -218M -91M 178M -72M -63M -19M -231M -73M 108M -31M -133M
inventory 16M 7M -42M -33M -143M -100M -62M -39M -128M -4M -56M
accountsPayables 0 0 145M 137M 51M 97M 165M 0 -8M 0 -96M
otherWorkingCapital 149M 12M -155M -1M 120M -148M -20M -155M -33M 13M 16M
otherNonCashItems -48M -78M 20M 667M 835M 165M 485M 83M 64M 493M -1 669M
netCashProvidedByOperatingActivities 405M 289M 411M 379M 206M 390M 282M 269M 154M 475M -1 263M
investmentsInPropertyPlantAndEquipment -91M -99M -69M -79M -83M -144M -46M -40M -51M -96M -59M
acquisitionsNet -5M 0 -40M 1M 995 533 -3M -1 856M 849 090 -31M 0 0
purchasesOfInvestments -1 000 000 -1 000 000 -2M -2M -3M -14M -2M 3M -13M -2M -1 000 000
salesMaturitiesOfInvestments 1 000 000 1 000 000 4M 1M 6M 13M 4M -3M 11M 2M 7M
otherInvestingActivites 13M -1 000 000 6M 43 799 6M 27 331 11M 1M 6M -40M 0
netCashUsedForInvestingActivites -83M -100M -102M -79M -73M -148M -1 889M -38M -78M -136M -53M
debtRepayment -705M 405M -164M -414M -314M -57M -817M -537M -279M -622M -141M
commonStockIssued 0 0 0 0 0 0 0 0 0 0 0
commonStockRepurchased 0 -3M 18M -4M -14M -1 000 000 -8M 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites -14M -44M -25M -9M -21M -58M 2 641M 382M 137M 346M 105M
netCashUsedProvidedByFinancingActivities -719M 358M -189M -423M -334M -79M 1 816M -155M -142M -276M -36M
effectOfForexChangesOnCash -6M 39M 13M -9M -5M 19M -17M 1M 6M 31M -30M
netChangeInCash -403M 586M 127M -131M -203M 182M 192M 61M -60M 94M -1 382M
cashAtEndOfPeriod 1 340M 1 743M 750M 623M 754M 962M 780M 779M 531M 591M 497M
cashAtBeginningOfPeriod 1 743M 1 157M 623M 754M 957M 780M 588M 718M 591M 497M 1 879M
operatingCashFlow 405M 289M 411M 379M 206M 390M 282M 269M 154M 475M -1 263M
capitalExpenditure -91M -99M -69M -79M -83M -144M -46M -40M -51M -96M -59M
freeCashFlow 314M 190M 342M 300M 123M 246M 236M 229M 103M 379M -1 322M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Earning call transcript

2025 q3
2025-10-29 ET (fiscal 2025 q3)
2025 q2
2025-07-30 ET (fiscal 2025 q2)
2025 q1
2025-04-30 ET (fiscal 2025 q1)
2024 q4
2025-02-19 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-08-01 ET (fiscal 2024 q2)
2024 q1
2024-05-02 ET (fiscal 2024 q1)
2023 q4
2024-02-22 ET (fiscal 2023 q4)
2023 q3
2023-11-02 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-04 ET (fiscal 2023 q1)
2022 q4
2023-02-23 ET (fiscal 2022 q4)
2022 q3
2022-11-03 ET (fiscal 2022 q3)
2022 q2
2022-08-09 ET (fiscal 2022 q2)
2022 q1
2022-05-10 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-12-23 17:27 ET
Bausch Health Companies published news for 2025 q3
SEC form 8
2025-12-23 17:27 ET
Bausch Health Companies published news for 2025 q3
SEC form 8
2025-12-12 17:30 ET
Bausch Health Companies published news for 2025 q3
SEC form 8
2025-12-12 17:30 ET
Bausch Health Companies published news for 2025 q3
SEC form 8
2025-12-09 00:30 ET
Bausch Health Companies published news for 2025 q3
SEC form 8
2025-12-09 00:30 ET
Bausch Health Companies published news for 2025 q3
SEC form 8
2025-11-24 12:10 ET
Bausch Health Companies published news for 2025 q3
SEC form 8
2025-11-24 12:10 ET
Bausch Health Companies published news for 2025 q3
SEC form 10
2025-10-29 22:09 ET
Bausch Health Companies reported for 2025 q3
SEC form 8
2025-10-29 20:09 ET
Bausch Health Companies reported for 2025 q3
SEC form 8
2025-10-29 20:09 ET
Bausch Health Companies published news for 2025 q3
SEC form 8
2025-09-11 13:52 ET
Bausch Health Companies published news for 2025 q2
SEC form 10
2025-07-30 22:36 ET
Bausch Health Companies reported for 2025 q2
SEC form 8
2025-07-30 20:12 ET
Bausch Health Companies reported for 2025 q2
SEC form 8
2025-07-30 20:12 ET
Bausch Health Companies published news for 2025 q2
SEC form 8
2025-07-29 11:01 ET
Bausch Health Companies published news for 2025 q2
SEC form 8
2025-07-29 11:01 ET
Bausch Health Companies published news for 2025 q2
SEC form 8
2025-06-18 20:58 ET
Bausch Health Companies published news for 2025 q1
SEC form 8
2025-06-18 20:58 ET
Bausch Health Companies published news for 2025 q1
SEC form 8
2025-06-10 13:10 ET
Bausch Health Companies published news for 2025 q1
SEC form 8
2025-06-10 13:10 ET
Bausch Health Companies published news for 2025 q1
SEC form 8
2025-05-21 00:15 ET
Bausch Health Companies published news for 2025 q1
SEC form 8
2025-05-21 00:15 ET
Bausch Health Companies published news for 2025 q1
SEC form 8
2025-05-21 00:15 ET
Bausch Health Companies published news for 2025 q1
SEC form 8
2025-05-21 00:15 ET
Bausch Health Companies published news for 2025 q1
SEC form 10
2025-05-01 00:00 ET
Bausch Health Companies reported for 2025 q1
SEC form 10
2025-04-30 22:03 ET
Bausch Health Companies reported for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Bausch Health Companies reported for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Bausch Health Companies published news for 2025 q1
SEC form 8
2025-03-25 18:40 ET
Bausch Health Companies published news for 2024 q4
SEC form 8
2025-03-25 18:40 ET
Bausch Health Companies published news for 2024 q4
SEC form 8
2025-03-19 15:57 ET
Bausch Health Companies published news for 2024 q4
SEC form 8
2025-03-19 15:57 ET
Bausch Health Companies published news for 2024 q4
SEC form 8
2025-03-19 15:57 ET
Bausch Health Companies published news for 2024 q4
SEC form 10
2025-02-20 00:32 ET
Bausch Health Companies published news for 2024 q4
SEC form 10
2025-02-20 00:00 ET
Bausch Health Companies reported for 2024 q4
SEC form 8
2025-02-19 00:00 ET
Bausch Health Companies reported for 2024 q4
SEC form 8
2025-02-19 00:00 ET
Bausch Health Companies published news for 2024 q4
SEC form 10
2024-10-31 00:00 ET
Bausch Health Companies reported for 2024 q3
SEC form 10
2024-10-30 19:13 ET
Bausch Health Companies reported for 2024 q3
SEC form 8
2024-10-30 16:16 ET
Bausch Health Companies reported for 2024 q3
SEC form 8
2024-10-30 16:16 ET
Bausch Health Companies published news for 2024 q3
SEC form 10
2024-08-01 16:45 ET
Bausch Health Companies published news for 2024 q2
SEC form 8
2024-08-01 07:07 ET
Bausch Health Companies reported for 2024 q2
SEC form 8
2024-08-01 07:07 ET
Bausch Health Companies published news for 2024 q2
SEC form 10
2024-08-01 00:00 ET
Bausch Health Companies published news for 2024 q2
SEC form 10
2024-05-02 16:57 ET
Bausch Health Companies published news for 2024 q1
SEC form 8
2024-05-02 07:03 ET
Bausch Health Companies reported for 2024 q1
SEC form 8
2024-05-02 07:03 ET
Bausch Health Companies published news for 2024 q1
SEC form 10
2024-05-02 00:00 ET
Bausch Health Companies published news for 2024 q1
SEC form 10
2024-02-22 17:04 ET
Bausch Health Companies published news for 2023 q4
SEC form 8
2024-02-22 07:04 ET
Bausch Health Companies reported for 2023 q4
SEC form 8
2024-02-22 07:04 ET
Bausch Health Companies published news for 2023 q4
SEC form 10
2024-02-22 00:00 ET
Bausch Health Companies published news for 2023 q4
SEC form 10
2023-11-02 16:58 ET
Bausch Health Companies published news for 2023 q3
SEC form 8
2023-11-02 07:05 ET
Bausch Health Companies reported for 2023 q3
SEC form 10
2023-11-02 00:00 ET
Bausch Health Companies published news for 2023 q3
SEC form 10
2023-08-03 16:46 ET
Bausch Health Companies published news for 2023 q2
SEC form 6
2023-08-03 07:05 ET
Bausch Health Companies reported for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Bausch Health Companies published news for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Bausch Health Companies published news for 2023 q2
SEC form 6
2023-07-07 08:07 ET
Bausch Health Companies published news for 2023 q2
SEC form 6
2023-07-07 08:06 ET
Bausch Health Companies published news for 2023 q2
SEC form 6
2023-06-30 09:17 ET
Bausch Health Companies published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Bausch Health Companies published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Bausch Health Companies published news for 2023 q1
SEC form 8
2023-02-23 00:00 ET
Bausch Health Companies reported for 2022 q4
SEC form 10
2023-02-23 00:00 ET
Bausch Health Companies reported for 2022 q4
SEC form 8
2022-11-03 00:00 ET
Bausch Health Companies reported for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Bausch Health Companies reported for 2022 q3
SEC form 8
2022-08-09 00:00 ET
Bausch Health Companies reported for 2022 q2
SEC form 10
2022-08-09 00:00 ET
Bausch Health Companies reported for 2022 q2
SEC form 8
2022-05-10 00:00 ET
Bausch Health Companies reported for 2022 q1
SEC form 10
2022-05-10 00:00 ET
Bausch Health Companies reported for 2022 q1
SEC form 8
2022-02-23 00:00 ET
Bausch Health Companies published news for 2021 q4
SEC form 10
2022-02-23 00:00 ET
Bausch Health Companies published news for 2021 q4
SEC form 10
2021-11-02 00:00 ET
Bausch Health Companies published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
Bausch Health Companies published news for 2021 q3
SEC form 10
2021-08-03 00:00 ET
Bausch Health Companies published news for 2021 q2
SEC form 8
2021-08-03 00:00 ET
Bausch Health Companies published news for 2021 q2
SEC form 10
2021-05-04 00:00 ET
Bausch Health Companies published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
Bausch Health Companies published news for 2021 q1